GNL Explorers — The Glucose Never Lies®

The Glucose Never Lies®

GNL Explorers
Put in your numbers. See what the evidence says.

Six interactive educational tools — each one built from peer-reviewed clinical trial data and validated against one of the largest real-world T1D datasets ever used to support an educational platform.

10,000+
People living with T1D across age, device type, and demographic groups
10+ yrs
Continuous CGM and insulin device data collected in everyday conditions
1.5M+
Patient-days assessed — sample sizes in the hundreds of thousands, p<0.001 throughout

Welcome back, . Your explorers are below — pick up where you left off.

Six explorers

Choose your starting point

Compare what the evidence says should happen on average to what you experience. That gap is where the learning is.

Activity & Exercise

10, 20, 30 Minutes Walking to Lower Highs

In the presence of insulin, exercise can lower glucose up to eight times faster than a correction dose. Enter your body weight, insulin on board, activity type, intensity, and duration — get your estimated glucose drop and carbohydrate requirement before, during, and after the session.

Alcohol & T1D

Alcohol Explorer New

Alcohol suppresses gluconeogenesis — meaning your liver cannot rescue you from a hypo the way it normally would. Enter what you drink, your body weight, and timing. The Explorer maps the average glucose risk window across the drinking period and overnight hours that follow.

AID Systems

AID Algorithm Optimiser

CamAPS FX, Control-IQ, Omnipod 5, MiniMed 780G — each algorithm works differently. Compare all four systems side by side: target glucose logic, correction behaviour, algorithm-calculated basal rates, and how your settings shape your outcomes.

Hypo & Hyper

Hypo & Hyper Treatment

The rule of 15 is a starting point. This Explorer calculates your personal glucose rise from fast-acting carbohydrate and your correction dose for hyperglycaemia — based on your actual TDD and body weight, not population averages. Treat more precisely. Correct without the rebound.

Exercise Planning

Planning for Before, During and After Exercise

Build a complete glucose management plan for any session — insulin adjustment, carbohydrate strategy, and recovery carbs — across multiple glucose bands. Adapts to MDI, pump, and AID therapy. Includes before, during, and after guidance plus overnight considerations for evening sessions.

Exercise IOB

Carbs for 30 Minutes Exercise

Insulin on board is the most important — and most invisible — factor in exercise hypoglycaemia risk. This Calculator estimates how much carbohydrate you may need for 30 minutes of activity based on your physiological IOB, body weight, and exercise type.

How to use the Explorers

Start with whatever you are most curious about

Use your own numbers. Each Explorer takes your body weight, TDD, and settings. The output is not a prescription — it is a picture of what the evidence suggests happens on average for someone in your situation. Compare it against your CGM data and talk through what you find with your diabetes care team.

All Explorers are for educational exploration only. They describe average physiological responses and general principles. They are not medical advice and cannot replace individual clinical guidance.

GNL Grace

Not sure which Explorer to use? Tell Grace what you want to explore and she will point you to the right tool and explain how to use it.

Ask Grace

Real-world validation

Validated against one of the largest real-world T1D datasets ever used to support an educational platform

Every GNL Explorer algorithm has been systematically tested against real-world population data accessed through an academic research collaboration. No other T1D education platform outside a pharmaceutical or device manufacturer setting has access to evidence at this scale.

10,000+
People living with T1D across age, device type, and demographic groups
10+ yrs
Continuous CGM and insulin device data collected in everyday conditions
1.5M+
Patient-days assessed — sample sizes in the hundreds of thousands, p<0.001 throughout
Validated against a real-world T1D dataset accessed through academic research collaboration. Findings are reported at a population-average level. Your personal response may differ.
Educational use only. These tools are built from clinical trial data and real-world patterns. They model how physiological principles behave on average — not how any individual will respond. They are not medical devices, not prescriptions, and must not be used as either. Any changes to your insulin settings, device configuration, or diabetes management must be made with your diabetes care team.
How GNL builds its tools and curates evidence →

Coming soon: CGM System Explorer — compare CGM accuracy, sensor wear patterns, and how to interpret CGM data across devices. Built in partnership with leading CGM researchers. More Explorers follow after that.

The Glucose Never Lies® — UK Registered Trade Mark UK00004267795. GNL Educational Explorer™ UK00004360249 (accepted for publication). GNL GRACE™ UK00004370619 (filed 9 April 2026).  •  The Glucose Never Lies Limited, registered in England & Wales, Company No. 16733595  •  Privacy Policy  •  Terms & Conditions